We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

98 hedge funds and large institutions have $96.9M invested in Palvella Therapeutics in 2019 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 31 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more call options, than puts

Call options by funds: $693K | Put options by funds: $305K

36% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 14

5% more funds holding

Funds holding: 93 → 98 (+5)

0.02% more ownership

Funds ownership: 0.7% → 0.72% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

13% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 31

25% less capital invested

Capital invested by funds: $129M → $96.9M (-$31.9M)

Holders
98
Holders Change
+5
Holders Change %
+5.38%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
19
Increased
27
Reduced
31
Closed
14
Calls
$693K
Puts
$305K
Net Calls
+$388K
Net Calls Change
+$383K

Top Buyers

Rank Fund Capital Flow
1
ACM
Aquilo Capital Management
California
+$7.29M
2
BI
BVF Inc
California
+$6.75M
3
BlackRock
BlackRock
New York
+$4.39M
4
CS
Candriam SCA
Luxembourg
+$3.19M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.9M

Top Sellers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
-$6.95M
2
Millennium Management
Millennium Management
New York
-$5.69M
3
American Century Companies
American Century Companies
Missouri
-$3.1M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.7M
5
FI
Fosun International
China
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
76
Allianz Asset Management
Germany
$39K -$387 -1 -0.7%
HF
77
HRT Financial
New York
$38K +$54.6K +141 New
JG
78
Jefferies Group
New York
$38K +$54.6K +141 New
State Board of Administration of Florida Retirement System
79
State Board of Administration of Florida Retirement System
Florida
$37K – – –
US Bancorp
80
US Bancorp
Minnesota
$35K – – –
SLF
81
Sun Life Financial
Ontario, Canada
$33K – – –
BNP Paribas Financial Markets
82
BNP Paribas Financial Markets
France
$28.3K +$9.68K +25 +32%
LC
83
Lindbrook Capital
California
$27K – – –
Legal & General Group
84
Legal & General Group
United Kingdom
$26K – – –
Victory Capital Management
85
Victory Capital Management
Texas
$25K +$36K +93 New
Citigroup
86
Citigroup
New York
$24K -$28.6K -74 -46%
IA
87
IFP Advisors
Florida
$21K +$27.5K +71 New
Group One Trading
88
Group One Trading
Illinois
$19K +$22.8K +59 +590%
Bank of Montreal
89
Bank of Montreal
Ontario, Canada
$16K +$3.1K +8 +16%
AIP
90
Ameritas Investment Partners
Nebraska
$10K – – –
CG
91
Cutler Group
California
$7K +$3.48K +9 +47%
DWA
92
Dorsey Wright & Associates
California
$7K +$10.5K +27 New
TRCT
93
Tower Research Capital (TRC)
New York
$4K -$22.8K -59 -81%
TC
94
Truvestments Capital
Florida
$4K -$774 -2 -11%
PNC Financial Services Group
95
PNC Financial Services Group
Pennsylvania
$3K – – –
TWA
96
TCI Wealth Advisors
Arizona
$3K +$2.71K +7 +175%
CAPTRUST Financial Advisors
97
CAPTRUST Financial Advisors
North Carolina
$2K – – –
LTFS
98
Ladenburg Thalmann Financial Services
Florida
$2K +$3.1K +8 New
NCM
99
Nantahala Capital Management
Connecticut
– -$6.95M -18,470 Closed
American Century Companies
100
American Century Companies
Missouri
– -$3.1M -8,246 Closed
1 2 3
4
5

PVLA Hedge Fund Activity: Q3 2019 in Review

98 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q3 2019, worth a combined $96.9M — down 25% from $129M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new PVLA positions and 14 closed out — a net gain of 5 holders — while 27 added to existing stakes and 31 trimmed.

The largest buyer was Aquilo Capital Management, adding an estimated $7.29M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $6.95M sold.

  • 98 institutional investors held Palvella Therapeutics (PVLA) as of Q3 2019, up from 93 in Q2 2019.
  • Funds reported $96.9M of Palvella Therapeutics stock for Q3 2019, down 25% quarter-over-quarter.
  • 19 funds opened new Palvella Therapeutics positions in Q3 2019 and 14 closed out, a net change of +5 holders.
  • The largest Palvella Therapeutics buyer in Q3 2019 was Aquilo Capital Management, an estimated $7.29M added.
  • The largest Palvella Therapeutics seller in Q3 2019 was Nantahala Capital Management, an estimated $6.95M sold.

Based on aggregated 13F filings for Q3 2019.